Berkshire Hathaway Inc. (BRKB)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 40,700.00 |
|---|---|
| 52-week range | 24,000.00 – 41,240.00 |
| Return, 1 month / 3 months | +11.1% / +16.4% |
| Return, 1 year / 3 years | +13.0% / +165.7% |
| Trend | Uptrend |
| RSI (14) | 83 |
| Volatility (1 year) | 16.8% |
| Worst drawdown (1 year) | -12.7% |
| Average daily value traded | 1,598.28M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Berkshire Hathaway is a holding company based in Omaha, Nebraska, that owns insurance businesses and a broad collection of operating companies. Its insurance operations include auto and general reinsurance, while its other subsidiaries span freight rail, utilities and energy, manufacturing, building products and retail. The company also holds equity stakes in publicly traded businesses across sectors such as consumer goods, technology and financial services. Its customers range from individual policyholders to industrial and commercial clients worldwide.
The shares are listed on the Buenos Aires Exchange in Argentina under the code BRKB, and the price on this page is in Argentine pesos (ARS). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Berkshire Hathaway Inc. (BRKB) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 40,700.00 on 22 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 6 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.0% and over the last three months it rose 16.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 16.4% | ||
| 6-month return | 30.4% | ||
| 12-month return, skipping the last month | 1.7% | ||
| Stability (higher is calmer) | 94 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.7% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 1,598.28M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | +11.1% |
| 3 months | +16.4% |
| 6 months | +30.4% |
| 1 year | +13.0% |
| 3 years | +165.7% |
| 5 years | +1,442.0% |
Signals
| 50-day / 200-day average | 37,205.60 / 34,477.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 592.94 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.